8-(Thiophen-3-yl)imidazo[1,2-c]pyrimidin-5(6H)-one

ID: ALA4742100

PubChem CID: 162647165

Max Phase: Preclinical

Molecular Formula: C10H7N3OS

Molecular Weight: 217.25

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=c1[nH]cc(-c2ccsc2)c2nccn12

Standard InChI:  InChI=1S/C10H7N3OS/c14-10-12-5-8(7-1-4-15-6-7)9-11-2-3-13(9)10/h1-6H,(H,12,14)

Standard InChI Key:  WBDHLAKASDYKFK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 15 17  0  0  0  0  0  0  0  0999 V2000
    1.6509   -2.0554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6509   -2.8726    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3562   -3.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0615   -2.8726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3562   -1.6426    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0623   -2.0559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6736   -1.5120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3452   -0.7626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5311   -0.8434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9418   -1.6526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7684   -3.2825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8496   -4.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6486   -4.2715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0586   -3.5645    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.5130   -2.9563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  1  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  1 10  2  0
  4 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 11  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4742100

    ---

Associated Targets(Human)

CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E1 (1877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLM-13 (2241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 217.25Molecular Weight (Monoisotopic): 217.0310AlogP: 1.75#Rotatable Bonds: 1
Polar Surface Area: 50.16Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.37CX Basic pKa: CX LogP: 1.29CX LogD: 1.29
Aromatic Rings: 3Heavy Atoms: 15QED Weighted: 0.67Np Likeness Score: -1.95

References

1. Jansa J,Jorda R,Škerlová J,Pachl P,Peřina M,Řezníčková E,Heger T,Gucký T,Řezáčová P,Lyčka A,Kryštof V.  (2021)  Imidazo[1,2-c]pyrimidin-5(6H)-one inhibitors of CDK2: Synthesis, kinase inhibition and co-crystal structure.,  216  [PMID:33711765] [10.1016/j.ejmech.2021.113309]

Source